Mahmoud Ali Kaykhaei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahmoud Ali Kaykhaei has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Hashemi
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
13 shared publications - Mohsen Taheri
Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir
8 shared publications Hamzeh Rezaei
Department of Clinical Biochemistry School of Medicine Zahedan University of Medical Sciences Zahedan IR Iran
5 shared publications- Mohammad Ali Mashhadi
Department of Hematology and Oncology, Zahedan University of Medical Sciences, Zahedan, Iran
5 shared publications - Ebrahim Eskandari-Nasab
Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
4 shared publications Behzad Narouie
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8927160
Association of miR‐499, miR‐27a, and miR‐34a Gene Polymorphisms With Susceptibility to Type 2 Diabetes Mellitus in an Iranian Population: A Case–Control Study
Background: Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder influenced by both environmental and genetic factors. MicroRNAs (miRNAs) are involved in the regulation of insulin signaling, inflammation, and pancreatic β ‐cell function. Genetic polymorphisms in miRNA‐related regions may contribute to interindividual differences in T2DM susceptibility, although their functional effects remain uncertain. Objective: This study is aimed at evaluating the association of five miRNA polymorphisms, miR‐499 rs3746444, miR‐27a rs895819/rs895519, miR‐34a rs6577555, miR‐124a rs531564, and miR‐146a rs2910164, with susceptibility to T2DM in an Iranian population. Methods: This case–control study included 200 patients with T2DM and 202 unrelated healthy controls from southeastern Iran. Genotyping was performed using T‐ARMS‐PCR and PCR‐RFLP methods. Genotype and allele distributions were compared between groups, Hardy–Weinberg equilibrium was assessed in controls, and crude odds ratios (ORs) were calculated under different genetic models. Multivariable logistic regression was also performed to estimate age‐ and sex‐adjusted ORs. Bonferroni correction was applied to account for multiple comparisons. Results: Significant associations with increased T2DM risk were observed for miR‐499 rs3746444 C allele (OR = 1.79, 95% CI = 1.34–2.39; p < 0.001), miR‐27a rs895819 G allele (OR = 1.89, 95% CI = 1.43–2.51; p < 0.001), and miR‐34a rs6577555 A allele (OR = 2.91, 95% CI = 2.19–3.88; p < 0.001). These associations remained evident in age‐ and sex‐adjusted codominant logistic regression models. In contrast, miR‐124a rs531564 and miR‐146a rs2910164 were not significantly associated with T2DM risk. Conclusion: The findings suggest that miR‐499 rs3746444, miR‐27a rs895819/rs895519, and miR‐34a rs6577555 polymorphisms are associated with T2DM susceptibility in this Iranian population. However, these results indicate association rather than causation, and further large‐scale, multiethnic, and functional studies are needed to confirm their biological and clinical relevance.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , 8927160
Open AccessAssociation of miR‐499, miR‐27a, and miR‐34a Gene Polymorphisms With Susceptibility to Type 2 Diabetes Mellitus in an Iranian Population: A Case–Control Study
Background: Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder influenced by both environmental and genetic factors. MicroRNAs (miRNAs) are involved in the regulation of insulin signaling, inflammation, and pancreatic β ‐cell function. Genetic polymorphisms in miRNA‐related regions may contribute to interindividual differences in T2DM susceptibility, although their functional effects remain uncertain. Objective: This study is aimed at evaluating the association of five miRNA polymorphisms, miR‐499 rs3746444, miR‐27a rs895819/rs895519, miR‐34a rs6577555, miR‐124a rs531564, and miR‐146a rs2910164, with susceptibility to T2DM in an Iranian population. Methods: This case–control study included 200 patients with T2DM and 202 unrelated healthy controls from southeastern Iran. Genotyping was performed using T‐ARMS‐PCR and PCR‐RFLP methods. Genotype and allele distributions were compared between groups, Hardy–Weinberg equilibrium was assessed in controls, and crude odds ratios (ORs) were calculated under different genetic models. Multivariable logistic regression was also performed to estimate age‐ and sex‐adjusted ORs. Bonferroni correction was applied to account for multiple comparisons. Results: Significant associations with increased T2DM risk were observed for miR‐499 rs3746444 C allele (OR = 1.79, 95% CI = 1.34–2.39; p < 0.001), miR‐27a rs895819 G allele (OR = 1.89, 95% CI = 1.43–2.51; p < 0.001), and miR‐34a rs6577555 A allele (OR = 2.91, 95% CI = 2.19–3.88; p < 0.001). These associations remained evident in age‐ and sex‐adjusted codominant logistic regression models. In contrast, miR‐124a rs531564 and miR‐146a rs2910164 were not significantly associated with T2DM risk. Conclusion: The findings suggest that miR‐499 rs3746444, miR‐27a rs895819/rs895519, and miR‐34a rs6577555 polymorphisms are associated with T2DM susceptibility in this Iranian population. However, these results indicate association rather than causation, and further large‐scale, multiethnic, and functional studies are needed to confirm their biological and clinical relevance.
- 20 June 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (1) , e8
Herniation of Optic Chiasm into the Sella Turcica
- 20 June 2025
- Published by Elsevier in Ophthalmology
- Vol. 133 (1) , e8
Herniation of Optic Chiasm into the Sella Turcica
- Open Access
- 17 February 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-10
Subacute thyroiditis in pregnancy: a narrative review
Thyroid dysfunction can adversely affect pregnancy outcomes. Apart from gestational thyrotoxicosis, thyroid dysfunction during pregnancy shares similar etiologies with the non-gravid state. Graves’ disease is the most common cause of spontaneous hyperthyroidism in pregnancy, followed by thyroid autonomy. Although subacute thyroiditis is a less common cause of thyrotoxicosis in pregnancy, its associated pain, systemic symptoms, and thyroid dysfunction can present diagnostic and therapeutic challenges. In its painful form, subacute thyroiditis may lead to severe disability, with systemic glucocorticoids being the best effective treatment option. When painless, the condition often comes to medical attention due to thyroid dysfunction. During the thyrotoxic phase, subacute thyroiditis should be differentiated from gestational thyrotoxicosis, Graves’ disease, and thyroid autonomy. Additionally, the transient hypothyroid phase may be misdiagnosed as permanent hypothyroidism, such as in Hashimoto’s thyroiditis. Once properly diagnosed, management is symptomatic and focused on correcting the predominant abnormality. In this review, we summarize the current reported cases of subacute thyroiditis in pregnancy and discuss the challenges in diagnosis and management. Clinical trial number Not applicable.
- 17 February 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-10
Open AccessSubacute thyroiditis in pregnancy: a narrative review
Thyroid dysfunction can adversely affect pregnancy outcomes. Apart from gestational thyrotoxicosis, thyroid dysfunction during pregnancy shares similar etiologies with the non-gravid state. Graves’ disease is the most common cause of spontaneous hyperthyroidism in pregnancy, followed by thyroid autonomy. Although subacute thyroiditis is a less common cause of thyrotoxicosis in pregnancy, its associated pain, systemic symptoms, and thyroid dysfunction can present diagnostic and therapeutic challenges. In its painful form, subacute thyroiditis may lead to severe disability, with systemic glucocorticoids being the best effective treatment option. When painless, the condition often comes to medical attention due to thyroid dysfunction. During the thyrotoxic phase, subacute thyroiditis should be differentiated from gestational thyrotoxicosis, Graves’ disease, and thyroid autonomy. Additionally, the transient hypothyroid phase may be misdiagnosed as permanent hypothyroidism, such as in Hashimoto’s thyroiditis. Once properly diagnosed, management is symptomatic and focused on correcting the predominant abnormality. In this review, we summarize the current reported cases of subacute thyroiditis in pregnancy and discuss the challenges in diagnosis and management. Clinical trial number Not applicable.
- 5 October 2024
- Published by Springer Nature in Clinical & Translational Metabolism
- Vol. 22 (1) , 1-8
Metabolic Syndrome in Patients with Chronic Kidney Disease
- 5 October 2024
- Published by Springer Nature in Clinical & Translational Metabolism
- Vol. 22 (1) , 1-8
Metabolic Syndrome in Patients with Chronic Kidney Disease
- Open Access
- 21 July 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (7) , e0277151
Association of indoor use of pesticides with CKD of unknown origin
Introduction: Chronic kidney disease (CKD) is a growing global health problem. Recently, an epidemic of CKD of unknown origin (CKDu), a form of CKD seen mostly in agricultural communities, has been emerged. One of the proposed causes of CKDu is pesticide use in farmers. On the other hand, the research on relation between indoor use of pesticides and CKDu is little. In this study, we aimed to investigate the association between indoor use of pesticide as well as the exposure time with CKDu. This study was done as part of the population-based cohort of Prospective Epidemiological Research Studies in Iran. We used the baseline data of the Zahedan Adult Cohort Study. All subjects with diabetes mellitus and/or hypertension, estimated glomerular filtration rate (eGFR) between 60–89 ml/min/1.73 m2, and unavailable creatinine measurement were excluded. Subjects with an eGFR of less than 60 ml/min/1.73 m2 were defined as having CKDu, and their data were compared with those with an eGFR of more than 90 ml/min/1.73 m2. Data regarding indoor pesticide use and duration of exposure were obtained through a questionnaire. After applying the exclusion criteria, 1079 subjects remained in the study. Female sex, single marital status, low physical activity, triglyceride (TG) levels of more than 150 mg/dl, body mass index (BMI) of more than 25 kg/m2, non-smokers, indoor pesticide use, and high pesticide exposure time were associated with CKDu. The effects of age, female sex, TG levels more than 150 mg/dl, pesticide use (OR 1.36; 95% CI 1.01–1.84), and high exposure time (third tertile of exposure time) compared to non-users (OR 1.64; 95% CI 1.07–2.51) remained significant in multivariable analysis. Conclusion: We found a positive association between pesticide use, as well as longer exposure time to pesticides, and impaired kidney function in cases without diabetes mellitus and hypertension. Further longitudinal studies should be carried out to confirm these findings.
- 21 July 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (7) , e0277151
Open AccessAssociation of indoor use of pesticides with CKD of unknown origin
Introduction: Chronic kidney disease (CKD) is a growing global health problem. Recently, an epidemic of CKD of unknown origin (CKDu), a form of CKD seen mostly in agricultural communities, has been emerged. One of the proposed causes of CKDu is pesticide use in farmers. On the other hand, the research on relation between indoor use of pesticides and CKDu is little. In this study, we aimed to investigate the association between indoor use of pesticide as well as the exposure time with CKDu. This study was done as part of the population-based cohort of Prospective Epidemiological Research Studies in Iran. We used the baseline data of the Zahedan Adult Cohort Study. All subjects with diabetes mellitus and/or hypertension, estimated glomerular filtration rate (eGFR) between 60–89 ml/min/1.73 m2, and unavailable creatinine measurement were excluded. Subjects with an eGFR of less than 60 ml/min/1.73 m2 were defined as having CKDu, and their data were compared with those with an eGFR of more than 90 ml/min/1.73 m2. Data regarding indoor pesticide use and duration of exposure were obtained through a questionnaire. After applying the exclusion criteria, 1079 subjects remained in the study. Female sex, single marital status, low physical activity, triglyceride (TG) levels of more than 150 mg/dl, body mass index (BMI) of more than 25 kg/m2, non-smokers, indoor pesticide use, and high pesticide exposure time were associated with CKDu. The effects of age, female sex, TG levels more than 150 mg/dl, pesticide use (OR 1.36; 95% CI 1.01–1.84), and high exposure time (third tertile of exposure time) compared to non-users (OR 1.64; 95% CI 1.07–2.51) remained significant in multivariable analysis. Conclusion: We found a positive association between pesticide use, as well as longer exposure time to pesticides, and impaired kidney function in cases without diabetes mellitus and hypertension. Further longitudinal studies should be carried out to confirm these findings.
- Open Access
- 18 September 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (18) , 10094
Association of miR-499 Polymorphism and Its Regulatory Networks with Hashimoto Thyroiditis Susceptibility: A Population-Based Case-Control Study
Hashimoto thyroiditis (HT) is a common autoimmune disorder with a strong genetic background. Several genetic factors have been suggested, yet numerous genetic contributors remain to be fully understood in HT pathogenesis. MicroRNAs (miRs) are gene expression regulators critically involved in biological processes, of which polymorphisms can alter their function, leading to pathologic conditions, including autoimmune diseases. We examined whether miR-499 rs3746444 polymorphism is associated with susceptibility to HT in an Iranian subpopulation. Furthermore, we investigated the potential interacting regulatory network of the miR-499. This case-control study included 150 HT patients and 152 healthy subjects. Genotyping of rs3746444 was performed by the PCR-RFLP method. Also, target genomic sites of the polymorphism were predicted using bioinformatics. Our results showed that miR-499 rs3746444 was positively associated with HT risk in heterozygous (OR = 3.32, 95%CI = 2.00–5.53, p < 0.001, CT vs. TT), homozygous (OR = 2.81, 95%CI = 1.30–6.10, p = 0.014, CC vs. TT), dominant (OR = 3.22, 95%CI = 1.97–5.25, p < 0.001, CT + CC vs. TT), overdominant (OR = 2.57, 95%CI = 1.62–4.09, p < 0.001, CC + TT vs. CT), and allelic (OR = 1.92, 95%CI = 1.37–2.69, p < 0.001, C vs. T) models. Mapping predicted target genes of miR-499 on tissue-specific-, co-expression-, and miR-TF networks indicated that main hub-driver nodes are implicated in regulating immune system functions, including immunorecognition and complement activity. We demonstrated that miR-499 rs3746444 is linked to HT susceptibility in our population. However, predicted regulatory networks revealed that this polymorphism is contributing to the regulation of immune system pathways.
- 18 September 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (18) , 10094
Open AccessAssociation of miR-499 Polymorphism and Its Regulatory Networks with Hashimoto Thyroiditis Susceptibility: A Population-Based Case-Control Study
Hashimoto thyroiditis (HT) is a common autoimmune disorder with a strong genetic background. Several genetic factors have been suggested, yet numerous genetic contributors remain to be fully understood in HT pathogenesis. MicroRNAs (miRs) are gene expression regulators critically involved in biological processes, of which polymorphisms can alter their function, leading to pathologic conditions, including autoimmune diseases. We examined whether miR-499 rs3746444 polymorphism is associated with susceptibility to HT in an Iranian subpopulation. Furthermore, we investigated the potential interacting regulatory network of the miR-499. This case-control study included 150 HT patients and 152 healthy subjects. Genotyping of rs3746444 was performed by the PCR-RFLP method. Also, target genomic sites of the polymorphism were predicted using bioinformatics. Our results showed that miR-499 rs3746444 was positively associated with HT risk in heterozygous (OR = 3.32, 95%CI = 2.00–5.53, p < 0.001, CT vs. TT), homozygous (OR = 2.81, 95%CI = 1.30–6.10, p = 0.014, CC vs. TT), dominant (OR = 3.22, 95%CI = 1.97–5.25, p < 0.001, CT + CC vs. TT), overdominant (OR = 2.57, 95%CI = 1.62–4.09, p < 0.001, CC + TT vs. CT), and allelic (OR = 1.92, 95%CI = 1.37–2.69, p < 0.001, C vs. T) models. Mapping predicted target genes of miR-499 on tissue-specific-, co-expression-, and miR-TF networks indicated that main hub-driver nodes are implicated in regulating immune system functions, including immunorecognition and complement activity. We demonstrated that miR-499 rs3746444 is linked to HT susceptibility in our population. However, predicted regulatory networks revealed that this polymorphism is contributing to the regulation of immune system pathways.
- 25 September 2020
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 23 (12) , 1692-1697
Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheumatoid arthritis: A preliminary randomized clinical trial
Aim: Chronic inflammation and subsequent use of glucocorticoids can lead to relative adrenocortical insufficiency in patients with rheumatoid arthritis (RA). Previously, adrenocortical hormone, dehydroepiandrosterone (DHEA) was shown as a potential therapy for autoimmune disorders. However, data regarding effects of DHEA in RA are limited. The aim of this study was to investigate the effects of DHEA on quality of life (QOL) in premenopausal rheumatoid arthritis patients.Method: In this randomized double blinded, controlled trial 46 premenopausal rheumatoid arthritis patients were assigned to receive 50 mg/d DHEA (23 patients) or placebo (23 patients) for 12 weeks. Disease Activity Score of 28 joints – erythrocyte sedimentation rate (DAS28‐ESR) questionnaire, visual analog score and swollen and tender joint counts (both 0‐28) were used for assessment of disease activity. Persian‐validated World Health Organization Quality of Life Brief version (WHOQOL BREF) questionnaire was used to assess quality of life.Results: In comparison to the control group more improvement in QOL (P = .025) and environment health (P = .001) was observed in the DHEA group. After adjustment for age and disease duration DHEA was associated with more improvement in QOL (P = .01), psychological (P = .02) and physical health (P = .03). A trend toward a decrease in ESR was observed in DHEA group (P = .06). DAS was improved in both groups; however, there was no significant change in DAS28 between groups (P = .88). Frequency of adverse events albeit minor was similar in both groups.Conclusion: Our study supports a slightly superior effect of DHEA over placebo to improve QOL in premenopausal female patients with rheumatoid arthritis. We did not find improvement in DAS in the DHEA group over placebo.
- 25 September 2020
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 23 (12) , 1692-1697
Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheumatoid arthritis: A preliminary randomized clinical trial
Aim: Chronic inflammation and subsequent use of glucocorticoids can lead to relative adrenocortical insufficiency in patients with rheumatoid arthritis (RA). Previously, adrenocortical hormone, dehydroepiandrosterone (DHEA) was shown as a potential therapy for autoimmune disorders. However, data regarding effects of DHEA in RA are limited. The aim of this study was to investigate the effects of DHEA on quality of life (QOL) in premenopausal rheumatoid arthritis patients.Method: In this randomized double blinded, controlled trial 46 premenopausal rheumatoid arthritis patients were assigned to receive 50 mg/d DHEA (23 patients) or placebo (23 patients) for 12 weeks. Disease Activity Score of 28 joints – erythrocyte sedimentation rate (DAS28‐ESR) questionnaire, visual analog score and swollen and tender joint counts (both 0‐28) were used for assessment of disease activity. Persian‐validated World Health Organization Quality of Life Brief version (WHOQOL BREF) questionnaire was used to assess quality of life.Results: In comparison to the control group more improvement in QOL (P = .025) and environment health (P = .001) was observed in the DHEA group. After adjustment for age and disease duration DHEA was associated with more improvement in QOL (P = .01), psychological (P = .02) and physical health (P = .03). A trend toward a decrease in ESR was observed in DHEA group (P = .06). DAS was improved in both groups; however, there was no significant change in DAS28 between groups (P = .88). Frequency of adverse events albeit minor was similar in both groups.Conclusion: Our study supports a slightly superior effect of DHEA over placebo to improve QOL in premenopausal female patients with rheumatoid arthritis. We did not find improvement in DAS in the DHEA group over placebo.
- Open Access
- 4 August 2019
- Published by Brieflands in International Journal of High Risk Behaviors and Addiction
- Vol. 8 (3)
Serum Fetuin-A and Adipsin Levels in Type II Diabetes Patients
Fetuin-A is a glycoprotein known as a biomarker for diabetes risk. Adipsin or complement factor D (CFD) plays a role in glucose tolerance, and metabolism. ...
- 4 August 2019
- Published by Brieflands in International Journal of High Risk Behaviors and Addiction
- Vol. 8 (3)
Open AccessSerum Fetuin-A and Adipsin Levels in Type II Diabetes Patients
Fetuin-A is a glycoprotein known as a biomarker for diabetes risk. Adipsin or complement factor D (CFD) plays a role in glucose tolerance, and metabolism. ...
- 14 March 2019
- Published by Springer Nature in Endocrine
- Vol. 64 (2) , 378-383
Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects
Vitamin D deficiency is a major health problem which affects about one billion people in the world. Although, vitamin D supplementation is recommended as standard treatment of vitamin D deficiency, there are controversies on dose response relationship. In this regard, the present study aimed to determine the impact of vitamin D3 supplement on raising of serum 25 hydroxyvitamin D[25(OH)D] in healthy subjects with varying degrees of vitamin D deficiency.
- 14 March 2019
- Published by Springer Nature in Endocrine
- Vol. 64 (2) , 378-383
Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects
Vitamin D deficiency is a major health problem which affects about one billion people in the world. Although, vitamin D supplementation is recommended as standard treatment of vitamin D deficiency, there are controversies on dose response relationship. In this regard, the present study aimed to determine the impact of vitamin D3 supplement on raising of serum 25 hydroxyvitamin D[25(OH)D] in healthy subjects with varying degrees of vitamin D deficiency.